Resultados de búsqueda - Lalit Mohan Sharma
- Mostrando 1 - 4 Resultados de 4
-
1
-
2
Donor coordination to support universal health coverage in Malawi por Lalit Mohan Sharma, Stephanie Heung, Pakwanja Twea, Ian Yoon, Jean Nyondo, Dalitso Laviwa, Kenasi Kasinje, Emilia Connolly, Dominic Nkhoma, Madalitso Chindamba, Mihereteab Teshome Tebeje, Eoghan Brady, Andrews Gunda, Emily Chirwa, Gerald Manthalu
Publicado 2024Artigo -
3
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) por Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang, C. Manegold, Román Pérez-Soler, Jean-Yves Douillard, Nicholas Thatcher, Fabrice Barlési, Taofeek K. Owonikoko, Y. Wang, Philippe Pultar, Jing Zhu, Rajesh Malik, Giuseppe Giaccone, Stephen Della‐Fiorentina, Stephen Begbie, Ross Jennens, Joshua Dass, K. Pittman, N.M. Ivanova, Tatyana Koynova, Petar Petrov, Antoaneta Tomova, Valentina Tzekova, Félix Couture, Vera Hirsh, Ronald L. Burkes, Randeep Sangha, Miloslav Ambruš, Terezie Janaskova, J Musil, J. Novotny, Petr Zatloukal, Jitka Jakesova, Kamil Klenha, Jaromı́r Roubec, J Vaňásek, Jérôme Fayette, Fabrice Barlési, Jaafar Bennouna-Louridi, C. Chouaïd, Julien Mazières, H. Vallerand, G. Robinet, P.-J. Souquet, D. Spaëth, Roland Schött, H. Léna, Y. Martinet, Claude El Kouri, Nathalie Baize, Arnaud Scherpereel, O. Molinier, F. Fuchs, K. Josten, C. Manegold, Norbert Marschner, Folker Schneller, Tobias R. Overbeck, Michael Thomas, Joachim von Pawel, Martin Reck, Wolfgang Schuette, Volker Hagen, Claus-Peter Schneider, V. Georgoulias, Ioannis Varthalitis, Kostas Zarogoulidis, K. Syrigos, Christos N. Papandreou, Csaba Böcskei, Eszter Csánky, Erzsébet Juhász, György Losonczy, Z. Mark, István Molnár, Zsolt Pápai-Székely, S. Tehenes, Ilona Vinkler, Sachin Almel, Ashish Bakshi, Shailesh Bondarde, A Maru, Ashutosh Pathak, R.M. Pedapenki, Krishna Prasad, S.V.S.S. Prasad, Nalini Kilara, D. Gorijavolu, Chetan Deshmukh, S.K.P. John, Lalit Mohan Sharma, D. Amoroso, Emilio Bajetta, Paolo Bidoli, Andrea Bonetti, Filippo de Marinis, Massimo Di Maïo, Rodolfo Passalacqua, Stefano Cascinu
Publicado 2013Artigo -
4
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial por Martin Schüler, James Chih‐Hsin Yang, K. Park, Jie‐Hyun Kim, Jaafar Bennouna, Y.-M. Chen, C. Chouaïd, Filippo de Marinis, Jinlun Feng, Francesco Grossi, D.-W. Kim, X. Liu, Shun Lü, János Strausz, Yuriy Vinnyk, Rainer Wiewrodt, Caicun Zhou, B. Wang, Vikram K. Chand, David Planchard, Sai‐Hong Ignatius Ou, David Planchard, Keunchil Park, Martin Schüler, James Chih‐Hsin Yang, Vikram K. Chand, Klaus Röhr, Claudia Bagnes, Claudio Martín, Gonzálo Recondo, Juan José Zarbá, C. Blajman, Martin Eduardo Richardet, Sue‐Anne McLachlan, Phillip Parente, Craig Underhill, Catherine Crombie, Paul N. Mainwaring, Richard Greil, Yves Humblet, F. Bustin, L Carestia, Danny Galdermans, Marc Lambrechts, Laetitia Delval, Piet Vercauter, Caicun Zhou, Jin Wang, Cheng Huang, Xiaoyan Lin, Yi‐Long Wu, Xiaoqing Liu, Ying Cheng, Shukui Qin, Jifeng Feng, Jianjin Huang, Yiping Zhang, Shun Lü, Manuela Zereu, Bernardo Garicochea, Cyntia Albuquerque Zadra, Henrik Riska, Tuomo Alanko, Jacques Cadranel, C. Chouaïd, Gérard Zalcman, Denis Moro‐Sibilot, M. Pérol, David Planchard, Jaafar Bennouna, P. Fournel, Radj Gervais, M. Rotarski, Bruno Coudert, Martin Schüler, Michael Thomas, Thomas Wehler, Martin Faehling, Ulrich Keilholz, Eckart Laack, Joachim von Pawel, Rudolf M. Huber, N Dickgreber, Rainer Wiewrodt, Z. Mark, S. Tehenes, János Strausz, Veronika Sárosi, Kumar Prabhash, Minish Jain, Venkatesan Srinivasan, Lalit Mohan Sharma, H. Dadhich, Rajnish Nagarkar, Amir Onn, Maya Gottfried, Salomon M. Stemmer, Maria Rita Migliorino, Francesco Grossi, Paolo Bidoli
Publicado 2015Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Cancer
Clinical endpoint
Lung cancer
Randomized controlled trial
Surgery
Afatinib
Alternative medicine
Astrobiology
Business
Cervical cancer
Chemotherapy
Confidence interval
Developing country
Economic growth
Economics
Environmental health
Epidermal growth factor receptor
Erlotinib
Erlotinib Hydrochloride
Gastroenterology
Gefitinib
Hazard ratio
Health care
Health policy
Odds ratio
Oncology
Paclitaxel
Pathology